In conclusion, the present study showed that dulaglutide was associated with a significantly higher UACR compared to semaglutide, especially in patients of younger age, male gender, with hypertension, without HF, those using ARBs, biguanides, and statins, and those who are not using SGLT2 inhibitors. This evidence concerns the gene SLC5A2 and hydrops fetalis.